Navigation Links
Young minority women screened at higher rate for chlamydia than young white women
Date:1/24/2011

INDIANAPOLIS A new study from the Indiana University School of Medicine and the Regenstrief Institute has found that Black and especially Hispanic young women are screened for chlamydia at a significantly higher rate than young white women. This discrepancy in screening rates may contribute to nationwide reporting of higher rates of this sexually transmitted disease among minority young women.

The research, which used data from more than 40,000 visits to health care facilities, appears in the February issue of the journal Pediatrics, published online ahead of print on Jan. 24.

Despite a recommendation from the U.S. Preventive Services Task Force to annually screen all sexually active young women for this disease, only about half of sexually active women, ages 14 to 25, who receive health care, are screened appropriately. The IU and Regenstrief researchers found that black young women were 2.7 times more likely and Hispanic young women 9.7 times more likely to be screened for chlamydia, compared with white young women.

In addition to race or ethnicity, the researchers found screening likelihood varied by insurance status and also by age. Women with public insurance had greater odds of chlamydia testing, compared with women with private insurance.

"For some common conditions like breast cancer, white women are more likely to receive a screening test like mammography. For chlamydia infections which are highly stigmatized STDs white women are less likely, while minority women are more likely, to receive screening. This may mean that providers make judgments about a woman's likelihood of infection based on her race or ethnicity. Yet in an asymptomatic condition like chlamydia, all sexually active young women should be screened," said study first author Sarah E. Wiehe, M.D., M.P.H., assistant professor of pediatrics at the IU School of Medicine and a Regenstrief Institute affiliated scientist.

A medical history of STDs was more important than race or ethnicity or insurance status in terms of differences in chlamydia screening. Young women who had a previous STD were more likely to be screened for chlamydia, no matter their race or ethnicity, and differences by race or ethnicity in testing decreased substantially in this subgroup. The same was not true for young women who had been pregnant in the past. After a pregnancy, young minority women were much more likely (24 times for Hispanic women and 4 times for black women) to be screened than young white women.

"Even when we accounted for provider-level differences in testing patterns, the bias to screen black and Hispanic young women persisted. We must encourage pediatricians, internists, family medicine physicians and gynecologists to screen all sexually active young women under their care. Chlamydia is a serious and usually asymptomatic disease that may have serious health repercussions," said Dr. Wiehe, a pediatrician and health services researcher.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related medicine news :

1. Phonak Asks Young FM Users to Tell Their Stories on YouTube
2. Young patients with chronic illnesses find relief in acupuncture
3. Rapid Flu Test Most Accurate for Young Kids
4. More Young Women Driving Drunk
5. Third of Young U.S. Adults Lack Health Insurance
6. Strokes Up Among the Young, Down Among the Old
7. Why symptoms of schizophrenia emerge in young adulthood
8. Young Men and Elderly Women at Biggest Risk for Shoulder Dislocations
9. SEBM Young Investigator Awards for 2010
10. KIWI Magazine Announces the Next Great Young Chef Contest--for Kids Who Love to Cook
11. Study: Kidney disease a big risk for younger, low-income minorities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Young minority women screened at higher rate for chlamydia than young white women
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... from Germany, announced it is bringing its product to the United States as part ... perfected over the last 25 years, Alcovit aims to reduce the productions of nasty ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based ... recently attended the January ECRM Trade Show in Hilton Head, SC, benefiting from ... large range of supplements that keep the body functioning at its peak performance ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: